GENITOURINARY CANCERS

Latest News

Relugolix Shows Strong Adherence in Medicare Patients With Prostate Cancer
Relugolix Shows Strong Adherence in Medicare Patients With Prostate Cancer

February 18th 2025

Over 90% adherence to relugolix in patients with Medicare with prostate cancer for 24 months supports its use as androgen deprivation therapy, per real-world study data.

Oral Relugolix Preferred Over Injectables in Advanced Prostate Cancer
Oral Relugolix Preferred Over Injectables in Advanced Prostate Cancer

February 17th 2025

Cemiplimab Plus Chemo Shows Benefit in Advanced Penile Cancer
Cemiplimab Plus Chemo Shows Benefit in Advanced Penile Cancer

February 17th 2025

Review Confirms Safety and Efficacy of Radium-223 in mCRPC
Review Confirms Safety and Efficacy of Radium-223 in mCRPC

February 15th 2025

High PSA Before HIFU Tied to Increased Recurrence, Treatment Failure
High PSA Before HIFU Tied to Increased Recurrence, Treatment Failure

February 14th 2025

More News